Emerging Blood Typing, Grouping & NAT Screening Technologies Report 2016-2020 - Analysis, Technologies & Forecasts - Key Vendors: Quest, - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/vgnfpt/20162020) has announced the addition of the "2016-2020 Emerging Blood Typing, Grouping and NAT Screening Technologies, and Strategic Profiles of Leading Suppliers" report to their offering.

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.

Competitive Assessments:

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • CellMark Forensics/LabCorp
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • Immucor
  • Ortho-Clinical Diagnostic
  • Proteome Sciences
  • Quest
  • Quidel
  • Roche
  • Siemens
  • Tecan
  • Thermo Fisher/Life Technologies

For more information visit http://www.researchandmarkets.com/research/vgnfpt/20162020

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Coagulation and Hemostasis Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Coagulation and Hemostasis Testing